Glimepiride; Rosiglitazone Maleate Patent Expiration
Glimepiride; Rosiglitazone Maleate is Used for improving glycemic control in adult patients with type 2 diabetes mellitus who are naive to pharmacologic therapy. It was first introduced by Sb Pharmco Puerto Rico Inc
Glimepiride; Rosiglitazone Maleate Patents
Given below is the list of patents protecting Glimepiride; Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avandaryl |
US7358366 (Pediatric) | Thiazolidinedione derivative and its use as antidiabetic |
Oct 19, 2020
(Expired) | Sb Pharmco |
| Avandaryl | US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
Apr 19, 2020
(Expired) | Sb Pharmco |
| Avandaryl |
US5741803 (Pediatric) | Substituted thiazolidinedionle derivatives |
Oct 21, 2015
(Expired) | Sb Pharmco |
| Avandaryl | US5741803 | Substituted thiazolidinedionle derivatives |
Apr 21, 2015
(Expired) | Sb Pharmco |
Glimepiride; Rosiglitazone Maleate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List